Drug
Levonorgestrel
Levonorgestrel: highest development phase Approved, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| SKYLA | Approved |
Latest
- SKYLA: patent 11628088 expires 2027-02-07
- Boxed warning added: LEVONORGESTREL
Follow Levonorgestrel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.